BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Reeves BN, Beckman JD. Novel Pathophysiological Mechanisms of Thrombosis in Myeloproliferative Neoplasms. Curr Hematol Malig Rep 2021;16:304-13. [PMID: 33876389 DOI: 10.1007/s11899-021-00630-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 10.0] [Reference Citation Analysis]
Number Citing Articles
1 De Meo ML, Spicer JD. The role of neutrophil extracellular traps in cancer progression and metastasis. Seminars in Immunology 2022. [DOI: 10.1016/j.smim.2022.101595] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
2 Reeves BN, Kim SJ, Song J, Wilson KJ, Henderson MW, Key NS, Pawlinski R, Prchal JT. Tissue factor activity is increased in neutrophils from JAK2 V617F-mutated essential thrombocythemia and polycythemia vera patients. Am J Hematol 2022;97:E37-40. [PMID: 34748652 DOI: 10.1002/ajh.26402] [Reference Citation Analysis]
3 Korsakova NE. Endothelium state in Ph-negative myeloproliferative neoplasms. Sibirskij nauchnyj medicinskij zhurnal 2021;41:30-44. [DOI: 10.18699/ssmj20210603] [Reference Citation Analysis]
4 Sant'Antonio E, Borsani O, Camerini C, Botta C, Santoro M, Allegra A, Siragusa S. Philadelphia chromosome-negative myeloproliferative neoplasms in younger adults: A critical discussion of unmet medical needs, with a focus on pregnancy. Blood Rev 2021;:100903. [PMID: 34742614 DOI: 10.1016/j.blre.2021.100903] [Reference Citation Analysis]
5 Thomas S, Krishnan A. Platelet Heterogeneity in Myeloproliferative Neoplasms. Arterioscler Thromb Vasc Biol 2021;41:2661-70. [PMID: 34615371 DOI: 10.1161/ATVBAHA.121.316373] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Catani L, Cavo M, Palandri F. The Power of Extracellular Vesicles in Myeloproliferative Neoplasms: "Crafting" a Microenvironment That Matters. Cells 2021;10:2316. [PMID: 34571965 DOI: 10.3390/cells10092316] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
7 Baldini C, Moriconi FR, Galimberti S, Libby P, De Caterina R. The JAK-STAT pathway: an emerging target for cardiovascular disease in rheumatoid arthritis and myeloproliferative neoplasms. Eur Heart J 2021:ehab447. [PMID: 34343257 DOI: 10.1093/eurheartj/ehab447] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 10.0] [Reference Citation Analysis]
8 Găman MA, Cozma MA, Dobrică EC, Crețoiu SM, Găman AM, Diaconu CC. Liquid Biopsy and Potential Liquid Biopsy-Based Biomarkers in Philadelphia-Negative Classical Myeloproliferative Neoplasms: A Systematic Review. Life (Basel) 2021;11:677. [PMID: 34357048 DOI: 10.3390/life11070677] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 16.0] [Reference Citation Analysis]
9 Lin HY, Lin CY, Shen MC. Review article inferior vena cava thrombosis: a case series of patients observed in Taiwan and literature review. Thromb J 2021;19:43. [PMID: 34158063 DOI: 10.1186/s12959-021-00296-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]